PT287 Josh Hardman Psychedelic Stocks, Data Privacy, and Drug Development

Published: Jan. 25, 2022, 6:24 a.m.

In this episode of the podcast, Joe interviews Josh Hardman, Founder and Editor of Psilocybin Alpha; a news website and weekly newsletter covering the psychedelic space with a focus on emerging companies and drug development.\xa0

www.psychedelicstoday.com